first large study of glp-1 receptor agonists during pregnancy Should be continued into early pregnancy? ➡️ Swipe to read the key takeaways from a recent target trial emulation on first-trimester GLP-1 receptor agonist use and GLP-1-Mediated Pregnancy and Neonatal Complications
Description
Cancer Med

Subgroup analyses (Figure 5) (exploratory) revealed similar directional trends across subgroups, including patients with organ transplantation (HR 0.27, 95% CI 0.090.82

In addition, skin problems such as hirsutism and androgenic alopecia cowing to the excessive levels of androgens might also occur (140143)

Legal documents also suggest that the manufacturer of Trulicity, Eli Lilly, knew of these risks and failed to adequately warn healthcare providers or patients of the dangers
No stimulants
